ArticleCase reports in oncology2014
Pancreatic cancer presenting as new-onset diabetes.
Article in Case reports in oncology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Current paradigm and futuristic vision on new-onset diabetes and pancreatic cancer research.Frontiers in pharmacology · 2025Review
- Role of Pancreatic Tumour-Derived Exosomes and Their Cargo in Pancreatic Cancer-Related Diabetes.International journal of molecular sciences · 2023Review
- The seemingly innocuous presentation of metastatic pancreatic tail cancer: a case report.Journal of medical case reports · 2019Article
- Expression of Smo in pancreatic cancer CD44Oncology letters · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pancreatic adenocarcinoma has an incidence rate nearly equal to the mortality rate and is the fourth leading cause of cancer-related death in the USA. This is largely due to late symptom onset and diagnosis. Evidence has emerged that new-onset diabetes may be a symptom caused by occult pancreatic cancer. We report the case of a middle-aged African American female who presented with hyperglycemia and persistent scapular tenderness. She was subsequently diagnosed with new-onset diabetes and metastatic pancreatic cancer confirmed by liver biopsy. She did not have diabetes or pre-diabetes in the 6 months prior to presentation. The following report will serve to emphasize the role of new-onset diabetes in certain patients as a warning sign necessitating further investigation for pancreatic cancer. New-onset diabetes associated with specific risk factors may prompt for early testing, detection and treatment of pancreatic cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.